UPDF AI

Patient‐reported Outcomes in Cancer: A Review of Recent Research and Policy Initiatives

J. Lipscomb,C. Gotay,C. Snyder

2007 · DOI: 10.3322/CA.57.5.278
Ca · 306 Citations

TLDR

The role of PRO measurement in the evaluation and approval of cancer therapies, the assessment of cancer care in the community, patient‐provider decision making in clinical oncology practice, and population surveillance of cancer patients and survivors is examined.